title: New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry.
abstract: As the first nationwide Korean prospective multicenter data collection registry, the Korea Acute Myocardial Infarction Registry (KAMIR) launched in November 2005. Through a number of innovative approaches, KAMIR suggested new horizons about acute myocardial infarction (AMI) which contains unique features of Asian patients from baseline characteristics to treatment strategy. Obesity paradox was existed in Korean AMI patients, whereas no gender differences among them. KAMIR score suggested new risk stratifying method with increased convenience and an enhanced accuracy for the prediction of adverse outcomes. Standard loading dose of clopidogrel was enough for Asian AMI patients. Triple antiplatelet therapy with aspirin, clopidogrel and cilostazol could improve clinical outcomes than dual antiplatelet therapy with aspirin and clopidogrel. Statin improved clinical outcomes even in AMI patients with very low LDL-C levels. The rate of percutaneous coronary intervention was higher and door-to-balloon time was shorter than the previous reports. Zotarolimus eluting stents as the 2nd generation drug-eluting stent (DES) was not superior to the 1st generation DES, in contrast to the western AMI studies. KAMIR made a cornerstone in the study of Korean AMI and expected to be new standards of care for AMI with the renewal of KAMIR design to overcome its pitfalls.
authors: Heart Center of Chonnam National University Hospital, Gwangju, Korea.
authors: Ki Hong
authors: KH
authors: Lee
authors: Myung Ho
authors: MH
authors: Jeong
authors: Youngkeun
authors: Y
authors: Ahn
authors: Myeong Chan
authors: MC
authors: Cho
authors: Chong Jin
authors: CJ
authors: Kim
authors: Young Jo
authors: YJ
authors: Kim
mesh_terms: D000208:Acute Disease; D054855:Drug-Eluting Stents; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012042:Registries; D056910:Republic of Korea; D012307:Risk Factors; D012720:Severity of Illness Index; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; C489443:zotarolimus; D020123:Sirolimus
keywords: Acute Myocardial Infarction; Non-ST-Elevation Myocardial Infarction; ST-Elevation Myocardial Infarction
references: J Korean Med Sci. 2011 Apr;26(4):521-7
references: 21468259
references: Am J Cardiol. 2011 Jul 15;108(2):206-13
references: 21712106
references: Am J Cardiol. 2008 Oct 15;102(8):957-65
references: 18929693
references: J Am Coll Cardiol. 2006 Jan 3;47(1):45-51
references: 16386663
references: Lancet. 2007 Sep 15;370(9591):937-48
references: 17869634
references: Am Heart J. 2004 Jan;147(1):133-9
references: 14691431
references: Am J Cardiol. 2011 Apr 1;107(7):965-971.e1
references: 21256468
references: N Engl J Med. 2006 Sep 14;355(11):1105-13
references: 16971717
references: J Am Coll Cardiol. 2009 Oct 6;54(15):1438-46
references: 19796737
references: Am J Cardiol. 2012 Mar 15;109(6):787-93
references: 22196789
references: J Cardiol. 2010 Jan;55(1):84-91
references: 20122553
references: Circulation. 2009 Dec 15;120(24):2455-61
references: 19948977
references: Int J Cardiol. 2010 Dec 3;145(3):450-4
references: 19541376
references: Am J Cardiol. 2010 Mar 15;105(6):813-8
references: 20211324
references: Circulation. 2006 Nov 7;114(19):2019-25
references: 17075010
references: Circulation. 2006 Nov 14;114(20):2148-53
references: 17060388
references: Yonsei Med J. 2010 Jan;51(1):58-68
references: 20046515
references: J Am Coll Cardiol. 2007 May 15;49(19):1924-30
references: 17498576
references: EuroIntervention. 2011 Dec;7(8):936-43
references: 21959255
references: N Engl J Med. 2006 Sep 14;355(11):1093-104
references: 16971716
references: Am Heart J. 2011 Feb;161(2):373-382.e1-3
references: 21315222
references: Cardiovasc Diabetol. 2011 Oct 31;10:95
references: 22035298
references: Am Heart J. 1995 Jul;130(1):51-8
references: 7611123
references: N Engl J Med. 2007 Mar 8;356(10):1009-19
references: 17296822
references: Int J Cardiol. 2012 Sep 6;159(3):205-10
references: 21402419
references: Am J Cardiol. 2009 May 15;103(10):1333-8
references: 19427424
references: JAMA. 2000 Aug 16;284(7):835-42
references: 10938172
references: J Am Coll Cardiol. 2007 Jul 31;50(5):463-70
references: 17662400
references: Arch Intern Med. 2003 Oct 27;163(19):2345-53
references: 14581255
references: Circ J. 2011;75(12):2798-804
references: 22008317
references: J Am Coll Cardiol. 2011 Oct 11;58(16):1664-71
references: 21982310
references: N Engl J Med. 2005 Aug 18;353(7):653-62
references: 16105989
references: J Am Coll Cardiol. 2008 Mar 18;51(11):1066-72
references: 18342223
references: Circulation. 2009 Jun 30;119(25):3207-14
references: 19528339
references: Int J Cardiol. 2008 Nov 12;130(2):227-34
references: 18077018
references: Korean Circ J. 2009 Jun;39(6):243-50
references: 19949630
references: Eur Heart J. 2011 Dec;32(23):2999-3054
references: 21873419
references: Eur Heart J. 2009 Feb;30(3):321-9
references: 19147604
references: JAMA. 2006 Oct 11;296(14):1749-56
references: 17032988
references: Int J Cardiol. 2010 Dec 3;145(3):516-8
references: 20394997
references: Clin Cardiol. 2010 Aug;33(8):E1-6
references: 20589943
references: Arch Intern Med. 1998 May 11;158(9):981-8
references: 9588431
references: Am J Cardiol. 2007 Apr 15;99(8):1027-32
references: 17437722
references: JACC Cardiovasc Interv. 2011 May;4(5):543-50
references: 21596327
references: JACC Cardiovasc Interv. 2010 May;3(5):498-506
references: 20488406